Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-10 Option Award | 2024-12-12 5:49 pm | N/A 2034-12-09 | Zymeworks Inc. | ZYME | Gallagher Neil Director | 31,000 | $0 | 31,000 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-02 9:54 pm | N/A 2034-04-01 | Zymeworks Inc. | ZYME | Gallagher Neil Director | 74,000 | $0 | 74,000 (Direct) | View |
Ownership | 2024-04-02 9:52 pm | N/A N/A | Zymeworks Inc. | ZYME | Gallagher Neil Director | 0 | $0 | 0 (Direct) | View |
| 2024-02-07 Option Award | 2024-02-09 4:05 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D | 47,813 | $0 | 117,188 (Direct) | View |
| 2024-02-07 Option Award | 2024-02-09 4:05 pm | N/A 2034-02-07 | Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D | 69,375 | $22.28 | 117,188 (Direct) | View |
| 2023-04-10 Option Award | 2023-04-12 4:02 pm | N/A 2033-04-10 | Syndax Pharmaceuticals Inc | SNDX | Gallagher Neil President, Head of R&D | 250,000 | $19.35 | 250,000 (Direct) | View |